Methylenetetrahydrofolate reductase haplotype tag single-nucleotide polymorphisms and risk of breast cancer.
Martin
Yvette N
YN
Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Olson
Janet E
JE
Ingle
James N
JN
Vierkant
Robert A
RA
Fredericksen
Zachary S
ZS
Pankratz
V Shane
VS
Wu
Yanhong
Y
Schaid
Daniel J
DJ
Sellers
Thomas A
TA
Weinshilboum
Richard M
RM
D000483:Alleles; D001943:Breast Neoplasms / Q000235:genetics* / Q000473:pathology; D005091:Exons; D005260:Female; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D005838:Genotype; D006239:Haplotypes; D006801:Humans; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics*; D015233:Models, Statistical; D011110:Polymorphism, Genetic; D020641:Polymorphism, Single Nucleotide; D012306:Risk
D042965:Methylenetetrahydrofolate Reductase (NADPH2)